Don't Miss out on Research Tools:
- Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Vaxart ( (VXRT) ) just unveiled an announcement.
Vaxart, Inc. has decided to terminate its Sales Agreement with Cantor Fitzgerald & Co. and B. Riley Securities, which allowed for an “at the market offering” of common stock since September 2021. Effective October 18, 2024, the company will stop selling shares under this agreement, having raised about $28.6 million by selling over 17.5 million shares without facing any termination penalties. This cessation means no further common stock will be offered or sold through this channel.
For detailed information about VXRT stock, go to TipRanks’ Stock Analysis page.
